-

Investor Notice: Robbins LLP Informs Investors of the Camping World Holdings, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Camping World Holdings, Inc. (NYSE: CWH) securities between April 29, 2025 and February 24, 2026. Camping World retails recreational vehicles (“RVs”), and related products and services in the United States.

Robbins LLP is Investigating Allegations that Camping World Holdings, Inc. (CWH) Misled Investors Regarding Inventory Management

Share

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Camping World Holdings, Inc. (CWH) Misled Investors Regarding Inventory Management

According to the complaint, during the class period, defendants failed to disclose to investors: (i) the Company overstated its ability to “surgically manage [its] inventory” to optimize profit using “data analytics;” (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require “strict, corrective inventory management objectives,” negatively impacting gross profit and margins; and (iv) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses.

Plaintiff alleges that on February 24, 2026, Camping World released disappointing fourth quarter 2025 financial results. Company also announced that it would be pausing its quarterly cash dividend, effective immediately, “following consideration of forecasted tax distributions, the reduced availability of excess tax distributions to fund dividend payments driven partly by the impact of recent tax law changes, and in consideration of the Company’s focus on reducing net debt leverage.” On this news, Camping World’s stock price fell $1.79, or 16.5%, to close at $9.06 per share on February 25, 2026.

What Now: You may be eligible to participate in the class action against Camping World Holdings, Inc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Camping World Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:CWH

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the ADMA Biologics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.For more information, submit...

Investor Notice: Robbins LLP Informs Investors of the Erasca, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

Robbins LLP is Investigating Allegations that the Officers and Directors of Blaize Holdings, Inc. (BZAI) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Blaize Holdings, Inc. (NASDAQ: BZAI) to determine whether certain Blaize Holdings, Inc. officers and directors violated securities laws and breached fiduciary duties to shareholders. Blaize Holdings, Inc. provides artificial intelligence (AI)-enabled edge computing solutions.In late April 2026, two separate short-seller reports were published within two days of each other, both raising concerns regarding Blaize’...
Back to Newsroom